Catalyst Wire Dossier Catalyst Wire Dossier

Galvokimig

· UCB Biopharma SRL
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Galvokimig, covering 2026-04-24 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis [Phase 2]

See pricing